BioCryst Pharmaceuticals shares owned by Rafferty Asset Management
Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Rafferty Asset Management
from 13F filings
Historical chart of Rafferty Asset Management investment in BioCryst Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including BioCryst Pharmaceuticals held by Rafferty Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in BioCryst Pharmaceuticals by Rafferty Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $2.8M | 371k | 7.60 |
| 2024-03-31 | $8.0M | 1.6M | 5.08 |
| 2023-09-30 | $5.7M | 808k | 7.08 |
| 2023-06-30 | $6.9M | 975k | 7.04 |
| 2023-03-31 | $6.8M | 821k | 8.34 |
| 2022-12-31 | $8.8M | 768k | 11.48 |
| 2022-09-30 | $6.5M | 515k | 12.60 |
| 2022-06-30 | $4.1M | 387k | 10.58 |
| 2022-03-31 | $5.4M | 332k | 16.26 |
| 2021-12-31 | $6.3M | 453k | 13.85 |
| 2021-09-30 | $2.9M | 205k | 14.37 |
| 2021-06-30 | $2.5M | 156k | 15.81 |
| 2021-03-31 | $2.7M | 264k | 10.17 |
| 2020-12-31 | $837k | 112k | 7.45 |
| 2020-09-30 | $1.8M | 526k | 3.44 |
| 2020-06-30 | $1.1M | 223k | 4.77 |
| 2020-03-31 | $34k | 17k | 1.98 |
| 2019-12-31 | $504k | 146k | 3.45 |
| 2019-09-30 | $776k | 271k | 2.86 |
| 2019-06-30 | $1.4M | 381k | 3.79 |
| 2019-03-31 | $855k | 105k | 8.14 |